Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lomitapide

EU orphan designation number: EU/3/10/823   
Active ingredient: Lomitapide
Indication: Treatment of familial chylomicronaemia
Sponsor: Aegerion Pharmaceuticals Limited
Lakeside House, 1 Furzeground Way, Stockley Park East, Uxbridge UB11 1BD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/12/2010 Orphan designation EMA/OD/089/10 (2010)9536 of 17/12/2010
21/02/2012 Transfer of orphan designation EMA/OD/089/10/T/01 (2012)1108 of 15/02/2012
08/03/2013 Change of name and/or address of sponsor
02/03/2015 Transfer of orphan designation EMA/OD/089/10/T/02 (2015)1439 of 26/02/2015